What Does 10mg Tirzepatide Cost in the UK?

Step 1: Understand why 10mg sits where it does in the dose schedule

Tirzepatide treatment starts at 2.5mg (a tolerability dose designed to let your system adjust) and moves upward through 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Reaching 10mg means you've already been on treatment for several months, titrated step by step under prescriber supervision. That context matters for cost: you're not buying a single pen in isolation, you're at a point in a supervised medical programme. The tirzepatide 10mg cost therefore reflects both the medicine itself and the ongoing clinical infrastructure behind it.

Since Eli Lilly revised its UK pricing in September 2025, private providers have adjusted their own rates accordingly. As widely reported, the highest-dose pen's list price roughly tripled, from around £122 to around £330. Mid-range doses like 10mg sit between those extremes, though exact retail pricing varies by provider and month. The full tirzepatide cost picture across all doses gives useful context if you're comparing what different stages of treatment are likely to cost over time.

One practical note: if you're coming from a lower dose and wondering what's ahead, the 5mg cost page and the 15mg cost page map the range either side.

Step 2: Look past the headline number to see what's actually included

It's genuinely frustrating to see a price online, feel relieved, and then discover the consultation is billed separately. That happens. Some providers advertise the medicine cost alone and add clinical fees, prescription charges, or delivery on top. Others include those elements but then apply dose-specific surcharges when you move up. The tirzepatide 10mg price from any provider needs to be read as a total, not a line item.

A legitimate price for a prescription-only medicine like this should cover at minimum: the clinical assessment, the prescription itself, the medicine, and delivery. If aftercare (follow-up support, dose-review conversations, clinical re-checks before repeat orders) comes at extra cost, that affects the true monthly figure. Mounjaro pricing in the UK varies enough that it's worth reading the detail before committing, rather than comparing headline numbers between providers.

There's also the NHS route to consider. Weight-loss treatment options from the NHS are expanding under NICE's phased rollout, but eligibility criteria are strict and waiting lists are real. Private treatment through a regulated pharmacy is the practical alternative for most people who want to start now. Our FAQs cover the NHS vs private question in plain terms if that's useful.

Step 3: Hear the honest version of where we stand on price

We're not the cheapest option for tirzepatide 10mg. That's a deliberate choice. Cheapest isn't a race we entered, because it's not a race worth winning with a prescription medicine. What a lower price usually signals isn't efficiency, it's something removed from the package.

At nume, one price covers your consultation, the prescription, the medicine, tracked delivery and aftercare. A GPhC-registered Independent Prescriber reviews your consultation personally before every supply, including repeats. There are no hidden fees, no subscriptions, and no auto-renewals. You can verify our pharmacy on the GPhC register (registration number 9012878). Current treatment pricing lives on our treatment page, and it's the same figure whatever dose you're on, no surprises at checkout.

If you want to know more about who reviews your consultation, our clinical team page gives that context.

Step 4: Why 'cheapest' is the wrong question for a prescription medicine

Tirzepatide pens sourced outside a licensed UK pharmacy carry real risks. The MHRA has warned publicly about counterfeit weight-loss pens sold through social media and unverified online sellers, in October 2025 the first illicit UK site producing fake tirzepatide pens was raided, following enforcement action that accounted for around 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million. Fake pens have contained insulin. That's not a theoretical risk.

The safe test for any provider is straightforward: can you verify them on the GPhC pharmacy register? Is a named prescriber making a clinical decision before supply? Is the medicine sourced through the licensed UK supply chain? If a price looks unusually low, or if you're offered a discount code for a prescription-only medicine, those are signals to pause. Reporting suspicious sellers can be done directly through the MHRA's Yellow Card scheme. For a fuller look at safe access to tirzepatide, the NHS tirzepatide medicines page is a solid starting point. A small difference in monthly cost isn't the measure that keeps the supply chain safe, clinical oversight and a verified pharmacy are.